drugset

drugset / Trial / NCT01303978

Phase II Proof-of-concept Study of APD421

NCT01303978 ↗

Phase 2 Completed 51 enrolled Acacia Pharma Ltd

NaSingle-groupOpen-labelPrevention

Summary

Evaluation of efficacy of APD421 in preventing nausea and vomiting caused by cisplatin

Timeline

Start: 2011-02
Primary completion: 2012-07
Completion: 2012-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Amisulpride	Small molecule	—	—

Indications